Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$17.13 - $26.91 $5.15 Million - $8.08 Million
-300,379 Reduced 74.93%
100,519 $2.07 Million
Q4 2023

Feb 14, 2024

SELL
$21.58 - $29.5 $8.51 Million - $11.6 Million
-394,335 Reduced 49.59%
400,898 $10.8 Million
Q3 2023

Nov 14, 2023

BUY
$25.8 - $39.97 $19.7 Million - $30.5 Million
761,873 Added 2283.79%
795,233 $23.6 Million
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $32.1 Million - $58.2 Million
-1,531,621 Reduced 97.87%
33,360 $1.19 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $10.6 Million - $15.6 Million
463,183 Added 42.04%
1,564,981 $36.7 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $20.3 Million - $47.8 Million
799,736 Added 264.76%
1,101,798 $30 Million
Q3 2022

Nov 14, 2022

SELL
$43.66 - $61.0 $7.19 Million - $10 Million
-164,698 Reduced 35.29%
302,062 $16.3 Million
Q2 2022

Aug 15, 2022

SELL
$28.82 - $77.35 $9.79 Million - $26.3 Million
-339,749 Reduced 42.13%
466,760 $18.8 Million
Q1 2022

May 16, 2022

BUY
$48.25 - $100.49 $15.9 Million - $33.2 Million
330,327 Added 69.37%
806,509 $53.4 Million
Q4 2021

Feb 14, 2022

BUY
$88.71 - $120.43 $42.2 Million - $57.3 Million
476,182 New
476,182 $47.6 Million
Q3 2021

Nov 15, 2021

SELL
$98.77 - $132.17 $26.8 Million - $35.8 Million
-270,947 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $29.7 Million - $44.9 Million
270,947 New
270,947 $33.6 Million
Q1 2021

May 17, 2021

SELL
$127.04 - $179.1 $24.1 Million - $34 Million
-190,022 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$99.96 - $135.93 $15.1 Million - $20.5 Million
150,734 Added 383.66%
190,022 $24.5 Million
Q3 2020

Nov 16, 2020

BUY
$80.32 - $111.8 $1.08 Million - $1.5 Million
13,406 Added 51.8%
39,288 $4.39 Million
Q2 2020

Aug 14, 2020

BUY
$60.49 - $97.5 $1.57 Million - $2.52 Million
25,882 New
25,882 $2.1 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.34B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.